NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Duane NashExecutive Chairman2025-06-1320,000$0.84
$16.70kBuy
Joerg NeermannDirector2025-06-0530,000$0.76
$22.80kBuy
Jason TardioPresident and COO2025-06-0512,512$0.79
$9.88kBuy
Jason TardioPresident and COO2025-06-0512,512$0.79
$9.88kBuy
Daniel VittCEO and Director2025-06-0415,000$0.77
$11.55kBuy
Joerg NeermannDirector2025-06-0470,000$0.77
$53.90kBuy
Daniel VittCEO and Director2025-06-0415,000$0.77
$11.55kBuy
Richard Alan RudickDirector2025-06-03143,075$0.70
$100.01kBuy
Glenn WhaleyChief Financial Officer2025-06-0345,000$0.71
$32.09kBuy
Glenn WhaleyChief Financial Officer2025-05-3025,000$0.56
$14.00kBuy

1 of 2

IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc9.29%8,902,972$7.39MInstitution
Soleus Capital Management LP7.61%7,293,007$6.05MInstitution
Muneer A. Satter7.44%7,132,277$5.92MInsider
Avidity Partners Management LP4.65%4,454,408$3.70MInstitution
Vanguard Group Inc4.10%3,931,548$3.26MInstitution
Focus Partners Wealth2.70%2,583,457$2.14MInstitution
V. Cooperatieve Ua Lsp2.26%2,162,782$1.80MInsider
Omega Fund Management LLC1.87%1,788,160$1.48MInstitution
Adage Capital Partners GP LLC1.46%1,398,600$1.16MInstitution
Fund Nv1.43%1,371,494$1.14MInsider

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX42.22%16.57%Net BuyingNet Buying
ARMP0.89%99.11%Net Selling
ENTX22.49%16.17%Net Buying
ACHV41.48%27.59%Net Buying
ZURA51.74%48.26%Net Selling

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 42.22% institutional shareholders, 16.57% Immunic insiders, and 41.21% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 7.44% of the company. Muneer A. Satter's Immunic shares are currently valued at $5.92M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.